ExploreWatchlistsPricing
  1. JP-listed companies
  2. KNC Laboratories Co., Ltd.
  3. Financials
  4. Cash from financing

KNC Laboratories Co., Ltd. (6568)

Market cap
¥9.6B
P/E ratio
12.4x
Develops and manufactures specialized organic chemicals for pharmaceutical, electronics, and biotech companies to accelerate their product development.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from financing (Million JPY)YoY (%)
Mar 31, 2026222-75.56%
Mar 31, 2025910+408.54%
Mar 31, 2024179-134.17%
Mar 31, 2023-523-1441.44%
Mar 31, 202239-121.66%
Mar 31, 2021-180-170.64%
Mar 31, 2020255-117.18%
Mar 31, 2019-1,484-157.28%
Mar 31, 20182,592-395.42%
Mar 31, 2017-877

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat